Growth modulation index (GMI) of larotrectinib versus prior systemic treatments for TRK fusion cancer patients Meeting Abstract


Authors: Italiano, A.; Hong, D. S.; Briggs, A.; Garcia-Foncillas, J.; Lassen, U. N.; Vassal, G.; Kummar, S.; van Tilburg, C. M.; Keating, K.; Reeves, J. A.; Fellous, M.; Nogai, H.; Laetsch, T. W.; Drilon, A.
Abstract Title: Growth modulation index (GMI) of larotrectinib versus prior systemic treatments for TRK fusion cancer patients
Meeting Title: ESMO Virtual Congress 2020
Journal Title: Annals of Oncology
Volume: 31
Issue: Suppl. 4
Meeting Dates: 2020 Sep 19-21/Oct 16-18
Meeting Location: Virtual
ISSN: 0923-7534
Publisher: Oxford University Press  
Date Published: 2020-09-01
Start Page: S473
End Page: S474
Language: English
ACCESSION: WOS:000573469100540
DOI: 10.1016/j.annonc.2020.08.656
PROVIDER: wos
Notes: Meeting Abstract: 542P -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Alexander Edward Drilon
    632 Drilon